Keisuke Taniuchi, President and Representative Director of our company, made a presentation on “Implementation of Drug Efficacy Evaluation Experiments of Nucleic Acid Compounds Targeting Small Nucleolar Low Molecular RNA in Pancreatic Cancer Cells” at the workshop of the 110th Annual Meeting of the Japanese Society of Gastroenterology held in Tokushima, Japan, from May 9 to 11, 2024. Drug efficacy evaluation experiments were conducted using human pancreatic cancer organoid transplanted mice.